Intermittent fasting for systemic triglyceride metabolic reprogramming (IFAST): Design and methods of a prospective, randomized, controlled trial.

Jacob A Quaytman, Natalie L David, Sharini Venugopal, Tânia Amorim, Britney Beatrice, Frederico G S Toledo, Rachel G Miller, Matthew L Steinhauser, Pouneh K Fazeli

Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. · pubmed

Paper

Abstract

Caloric restriction prolongs lifespan in model organisms and improves metrics of aging-related diseases in humans, but daily compliance is challenging. Intermittent fasting improves metrics of lipid and glucose metabolism in the setting of weight loss but whether these metrics are improved independent of weight loss is not known.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates intermittent fasting and its effects on triglyceride metabolism, which is relevant to understanding metabolic processes associated with aging. However, the focus on weight loss metrics and the design of a controlled trial suggest that while it contributes to the field, it does not present groundbreaking findings or address the root causes of aging directly. Thus, it is a solid piece of research but with limited impact.

Author of this paper? Send a correction.